Skip to content

IMOvifa Perimeter Reference Database

IMOvifa Perimeter Reference Database

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05792046
Enrollment
376
Registered
2023-03-30
Start date
2023-03-01
Completion date
2023-09-22
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Eyes

Brief summary

This study will collect data to establish a reference database for the IMOvifa perimeter.

Detailed description

This study will collect data from a reference population to be used as inputs to the calculation of age corrected significance limits for expected visual function sensitivity to establish reference limits for key output parameters for select test patterns of the IMOvifa perimeter device.

Interventions

test for detecting loss in visual function

Sponsors

New View Optometric Center
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 22 years of age or older on the date of informed consent * Able to understand the written informed consent and willing to participate * IOP ≤ 21 mmHg (each eye) * BCVA 20/40 or better (each eye) * Both eyes free of ocular conditions that may affect visual function (at doctor's discretion)

Exclusion criteria

* Unable to tolerate ophthalmic imaging and/or VF testing * History of conditions known to adversely affect visual function (at doctor discretion) * Spherical Equivalent refractive error outside the range from +6 Diopters * Cylindrical refractive error outside the range +2.5 Diopters

Design outcomes

Primary

MeasureTime frameDescription
Reference limit for mean deviationDay 1Visual sensitivity level in decibels

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026